Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Navigating the Aftermath: A Comprehensive Scoping Review on Follow-up Strategies After Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma.
Schuil HW, Figaroa OJA, Hendriks N, Schout BMA, Beerlage HP, van Jamaludin FS, M E L Henderickx M, van Moorselaar RJA, Kamphuis GM, Baard J. Schuil HW, et al. Among authors: van moorselaar rja. Eur Urol Open Sci. 2024 Jul 3;66:82-92. doi: 10.1016/j.euros.2024.06.005. eCollection 2024 Aug. Eur Urol Open Sci. 2024. PMID: 39050911 Free PMC article. Review.
Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non-muscle-invasive Bladder Cancer.
Hentschel AE, Blankvoort CJ, Bosschieter J, Vis AN, van Moorselaar RJA, Bosmans JE, Nieuwenhuijzen JA. Hentschel AE, et al. Among authors: van moorselaar rja. Eur Urol Open Sci. 2022 Jan 17;37:7-13. doi: 10.1016/j.euros.2021.12.008. eCollection 2022 Mar. Eur Urol Open Sci. 2022. PMID: 35243387 Free PMC article.
Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer.
de Ruiter BM, van Hattum JW, Lipman D, de Reijke TM, van Moorselaar RJA, van Gennep EJ, Maartje Piet AH, Donker M, van der Hulle T, Voortman J, Oddens JR, Hulshof MCCM, Bins AD. de Ruiter BM, et al. Among authors: van hattum jw, van gennep ej, van moorselaar rja, van der hulle t. Eur Urol. 2022 Nov;82(5):518-526. doi: 10.1016/j.eururo.2022.07.009. Epub 2022 Aug 3. Eur Urol. 2022. PMID: 35933242 Free article. Clinical Trial.
Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting.
Mehra N, Kloots I, Vlaming M, Aluwini S, Dewulf E, Oprea-Lager DE, van der Poel H, Stoevelaar H, Yakar D, Bangma CH, Bekers E, van den Bergh R, Bergman AM, van den Berkmortel F, Boudewijns S, Dinjens WNM, Fütterer J, van der Hulle T, Jenster G, Kroeze LI, van Kruchten M, van Leenders G, van Leeuwen PJ, de Leng WWJ, van Moorselaar RJA, Noordzij W, Oldenburg RA, van Oort IM, Oving I, Schalken JA, Schoots IG, Schuuring E, Smeenk RJ, Vanneste BGL, Vegt E, Vis AN, de Vries K, Willemse PM, Wondergem M, Ausems M. Mehra N, et al. Among authors: van kruchten m, van oort im, van der poel h, van den berkmortel f, van leeuwen pj, van moorselaar rja, van leenders g, van den bergh r, van der hulle t. Eur Urol Open Sci. 2023 Jan 25;49:23-31. doi: 10.1016/j.euros.2022.11.011. eCollection 2023 Mar. Eur Urol Open Sci. 2023. PMID: 36874601 Free PMC article.
A Systematic Review on the Impact of Quality Assurance Programs on Outcomes after Radical Prostatectomy.
van der Graaf SH, Hagens MJ, Veerman H, Roeleveld TA, Nieuwenhuijzen JA, Wit EMK, W J M Wouters M, van der Mierden S, van Moorselaar RJA, Beerlage HP, Vis AN, van Leeuwen PJ, van der Poel HG. van der Graaf SH, et al. Among authors: van moorselaar rja. Eur Urol Focus. 2024 Sep;10(5):754-760. doi: 10.1016/j.euf.2024.03.004. Epub 2024 Apr 16. Eur Urol Focus. 2024. PMID: 38631992 Review.
185 results